Home Cart 0 Sign in  
X

[ CAS No. 27007-53-0 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 27007-53-0
Chemical Structure| 27007-53-0
Chemical Structure| 27007-53-0
Structure of 27007-53-0 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 27007-53-0 ]

Related Doc. of [ 27007-53-0 ]

Alternatived Products of [ 27007-53-0 ]

Product Details of [ 27007-53-0 ]

CAS No. :27007-53-0 MDL No. :MFCD00144763
Formula : C8H6BrClO2 Boiling Point : -
Linear Structure Formula :- InChI Key :BIECSXCXIXHDBC-UHFFFAOYSA-N
M.W : 249.49 Pubchem ID :280500
Synonyms :

Calculated chemistry of [ 27007-53-0 ]

Physicochemical Properties

Num. heavy atoms : 12
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.12
Num. rotatable bonds : 2
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 50.43
TPSA : 26.3 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -4.9 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.46
Log Po/w (XLOGP3) : 4.12
Log Po/w (WLOGP) : 2.89
Log Po/w (MLOGP) : 3.24
Log Po/w (SILICOS-IT) : 3.01
Consensus Log Po/w : 3.14

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -4.22
Solubility : 0.015 mg/ml ; 0.0000602 mol/l
Class : Moderately soluble
Log S (Ali) : -4.38
Solubility : 0.0104 mg/ml ; 0.0000418 mol/l
Class : Moderately soluble
Log S (SILICOS-IT) : -3.95
Solubility : 0.0282 mg/ml ; 0.000113 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 2.0
Synthetic accessibility : 1.68

Safety of [ 27007-53-0 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 27007-53-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 27007-53-0 ]
  • Downstream synthetic route of [ 27007-53-0 ]

[ 27007-53-0 ] Synthesis Path-Upstream   1~12

  • 1
  • [ 27007-53-0 ]
  • [ 124-42-5 ]
  • [ 7142-09-8 ]
Reference: [1] Chemical Communications, 2008, # 47, p. 6333 - 6335
  • 2
  • [ 21739-93-5 ]
  • [ 27007-53-0 ]
YieldReaction ConditionsOperation in experiment
92% With hydrogenchloride In methanol Step 1.
methyl 2-bromo-5-chlorobenzoate
Into a stirred solution of 2-bromo-5-chlorobenzoic acid (11 g, 46.7 mmol, HPLC RT=2.99 min) in methanol (250 mL) at 0° C. was bubbled HCl gas.
The reaction was allowed to warm to room temperature and stirred overnight.
The reaction mixture was concentrated in vacuo to give an orange oil, which was purified by flash chromatography using hexanes as eluant to give methyl 2-bromo-5-chlorobenzoate as a colorless oil (10.7 g, 92percent yield). TLC Rf=0.6 (5percent EtOAc-hexanes); HPLC RT=3.48 min (Method A); 1H NMR (CDl3, 400 MHz) 7.78 ppm (d, 1H, J=2.6 Hz); 7.59 ppm (d, 1H, J=12.81 Hz);7.30 ppm (dd, 1H, J=8.6, 2.5 Hz); 3.94 ppm (s, 3H).
92% With hydrogenchloride In methanol Step 1.
methyl 2-bromo-5-chlorobenzoate
Into a stirred solution of 2-bromo-5-chlorobenzoic acid (11 g, 46.7 mmol, HPLC RT=2.99 min) in methanol (250 mL) at 0° C. was bubbled HCl gas.
The reaction was allowed to warm to room temperature and stirred overnight.
The reaction mixture was concentrated in vacuo to give an orange oil, which was purified by flash chromatography using hexanes as eluant to give methyl 2-bromo-5-chlorobenzoate as a colorless oil (10.7 g, 92percent yield). TLC Rf=0.6 (5percent EtOAc-hexanes); HPLC RT=3.48 min (Method A); 1H NMR (CDCl3, 400 MHz) 7.78 ppm (d, 1H, J=2.6 Hz); 7.59 ppm (d, 1H, J=12.81 Hz);7.30 ppm (dd, 1H, J=8.6, 2.5 Hz); 3.94 ppm (s, 3H).
92% With hydrogenchloride In methanol Step 1.
Into a stirred solution of 2-bromo-5-chlorobenzoic acid (11 g, 46.7 mmol, HPLC RT=2.99 min) in methanol (250 mL) at 0° C. was bubbled HCl gas.
The reaction was allowed to warm to room temperature and stirred overnight.
The reaction mixture was concentrated in vacuo to give an orange oil, which was purified by flash chromatography using hexanes as eluant to give methyl 2-bromo-5-chlorobenzoate as a colorless oil (10.7 g, 92percent yield). TLC Rf=0.6 (5percent EtOAc-hexanes); HPLC RT=3.48 min, method A; 1H NMR (CDCl3, 400 MHz) 7.78 ppm (d, 1H, J=2.6 Hz); 7.59 ppm (d, 1H, J=12.81 Hz);7.30 ppm (dd, 1H, J=8.6,2.5 Hz); 3.94 ppm (s, 3H).
Reference: [1] Patent: US2003/13700, 2003, A1,
[2] Patent: US6528503, 2003, B2,
[3] Patent: US2002/119992, 2002, A1,
  • 3
  • [ 67-56-1 ]
  • [ 21739-93-5 ]
  • [ 27007-53-0 ]
YieldReaction ConditionsOperation in experiment
4.17 g for 3 h; Reflux 2-bromo-5-chlorobenzoic acid (4g, 0.Ol6mol) was dissolved in MeOH (20m1) and sulphuric acid (imI) was added. The reaction was refluxed for 3h then cooled at RT. Water (20m1) was added and the solid was filtered, dissolved in DCM and washed with saturated aqueous solution of NaHCO3. The organic solvent was dried (Na2SO4) and evaporated to obtain 4.17g of the title compound as oil.1HNMR (CDCl3) 5 ppm= 7.81(d,1H), 7.61(d,1H),7.33(dd,1H), 3.96 (s,3H).
4.17 g for 3 h; Reflux 2-bromo-5-chlorobenzoic acid (4 g, 0.016 mol) was dissolved in MeOH (20 ml) and sulphuric acid (1 ml) was added. The reaction was refluxed for 3 h then cooled at RT. Water (20 ml) was added and the solid was filtered, dissolved in DCM and washed with saturated aqueous solution of NaHCO3. The organic solvent was dried (Na2SO4) and evaporated to obtain 4.17 g of the title compound as oil. 1HNMR (CDCl3) δ ppm=7.81 (d, 1H), 7.61 (d, 1H), 7.33 (dd, 1H), 3.96 (s, 3H).
4.17 g for 3 h; Reflux 2-bromo-5-chlorobenzoic acid (4 g, 0.016 mol) was dissolved in MeOH (20 ml) and sulphuric acid (1 ml) was added. The reaction was refluxed for 3 h then cooled at RT. Water (20 ml) was added and the solid was filtered, dissolved in DCM and washed with saturated aqueous solution of NaHCO3. The organic solvent was dried (Na2SO4) and evaporated to obtain 4.17 g of the title compound as oil. 1HNMR (CDCl3) δ ppm=7.81 (d, 1H), 7.61 (d, 1H), 7.33 (dd, 1H), 3.96 (s, 3H).
Reference: [1] Antimicrobial Agents and Chemotherapy, 2016, vol. 60, # 7, p. 3980 - 3987
[2] Bioorganic and Medicinal Chemistry Letters, 2003, vol. 13, # 20, p. 3477 - 3482
[3] Patent: WO2010/53210, 2010, A1, . Location in patent: Page/Page column 34
[4] Patent: WO2013/92893, 2013, A1, . Location in patent: Page/Page column 34; 35
[5] Patent: WO2013/127913, 2013, A1, . Location in patent: Page/Page column 50; 51
[6] Patent: WO2014/25658, 2014, A1, . Location in patent: Page/Page column 24
[7] Patent: US2014/357653, 2014, A1, . Location in patent: Paragraph 0185; 0186; 0187
[8] Patent: US2015/51226, 2015, A1, . Location in patent: Paragraph 0271; 0272; 0273
[9] Tetrahedron, 2016, vol. 72, # 24, p. 3454 - 3467
[10] Organic and Biomolecular Chemistry, 2017, vol. 15, # 22, p. 4831 - 4841
[11] Patent: WO2017/139603, 2017, A1, . Location in patent: Page/Page column 112
[12] Organic Letters, 2018, vol. 20, # 5, p. 1316 - 1319
  • 4
  • [ 79-37-8 ]
  • [ 21739-93-5 ]
  • [ 27007-53-0 ]
Reference: [1] Patent: US2003/153570, 2003, A1,
  • 5
  • [ 21739-93-5 ]
  • [ 18107-18-1 ]
  • [ 27007-53-0 ]
Reference: [1] Angewandte Chemie - International Edition, 2013, vol. 52, # 14, p. 3878 - 3882[2] Angew. Chem., 2013, vol. 125, # 14, p. 4132
[3] Organic Letters, 2016, vol. 18, # 13, p. 3102 - 3105
  • 6
  • [ 56961-26-3 ]
  • [ 27007-53-0 ]
Reference: [1] Patent: US2002/119992, 2002, A1,
  • 7
  • [ 21739-93-5 ]
  • [ 77-78-1 ]
  • [ 27007-53-0 ]
Reference: [1] Journal of Medicinal Chemistry, 2011, vol. 54, # 20, p. 7232 - 7246
  • 8
  • [ 14221-01-3 ]
  • [ 27007-53-0 ]
  • [ 439117-38-1 ]
Reference: [1] Patent: US2003/13700, 2003, A1,
[2] Patent: US6528503, 2003, B2,
[3] Patent: US2003/158218, 2003, A1,
[4] Patent: US2002/193398, 2002, A1,
[5] Patent: US2002/119992, 2002, A1,
  • 9
  • [ 557-21-1 ]
  • [ 27007-53-0 ]
  • [ 439117-38-1 ]
Reference: [1] Patent: WO2014/25658, 2014, A1, . Location in patent: Page/Page column 25
[2] Patent: WO2017/139603, 2017, A1, . Location in patent: Page/Page column 112
  • 10
  • [ 27007-53-0 ]
  • [ 544-92-3 ]
  • [ 27007-54-1 ]
  • [ 439117-38-1 ]
Reference: [1] Journal of Organic Chemistry, 2004, vol. 69, # 11, p. 3620 - 3627
  • 11
  • [ 27007-53-0 ]
  • [ 557-21-1 ]
  • [ 439117-38-1 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2003, vol. 13, # 20, p. 3477 - 3482
[2] Bioorganic and Medicinal Chemistry Letters, 2004, vol. 14, # 16, p. 4161 - 4164
  • 12
  • [ 27007-53-0 ]
  • [ 60666-70-8 ]
Reference: [1] Patent: WO2005/100298, 2005, A1, . Location in patent: Page/Page column 55
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 27007-53-0 ]

Aryls

Chemical Structure| 933585-58-1

[ 933585-58-1 ]

Methyl 3-bromo-5-chlorobenzoate

Similarity: 0.92

Chemical Structure| 117738-81-5

[ 117738-81-5 ]

Methyl 4-bromo-3,5-dichlorobenzoate

Similarity: 0.91

Chemical Structure| 107947-17-1

[ 107947-17-1 ]

Methyl 3-bromo-4-chlorobenzoate

Similarity: 0.89

Chemical Structure| 936-08-3

[ 936-08-3 ]

2-Bromo-4-chlorobenzoic acid

Similarity: 0.89

Chemical Structure| 1160574-85-5

[ 1160574-85-5 ]

Ethyl 3-bromo-4,5-dichlorobenzoate

Similarity: 0.88

Bromides

Chemical Structure| 933585-58-1

[ 933585-58-1 ]

Methyl 3-bromo-5-chlorobenzoate

Similarity: 0.92

Chemical Structure| 117738-81-5

[ 117738-81-5 ]

Methyl 4-bromo-3,5-dichlorobenzoate

Similarity: 0.91

Chemical Structure| 107947-17-1

[ 107947-17-1 ]

Methyl 3-bromo-4-chlorobenzoate

Similarity: 0.89

Chemical Structure| 936-08-3

[ 936-08-3 ]

2-Bromo-4-chlorobenzoic acid

Similarity: 0.89

Chemical Structure| 1160574-85-5

[ 1160574-85-5 ]

Ethyl 3-bromo-4,5-dichlorobenzoate

Similarity: 0.88

Chlorides

Chemical Structure| 933585-58-1

[ 933585-58-1 ]

Methyl 3-bromo-5-chlorobenzoate

Similarity: 0.92

Chemical Structure| 117738-81-5

[ 117738-81-5 ]

Methyl 4-bromo-3,5-dichlorobenzoate

Similarity: 0.91

Chemical Structure| 107947-17-1

[ 107947-17-1 ]

Methyl 3-bromo-4-chlorobenzoate

Similarity: 0.89

Chemical Structure| 936-08-3

[ 936-08-3 ]

2-Bromo-4-chlorobenzoic acid

Similarity: 0.89

Chemical Structure| 1160574-85-5

[ 1160574-85-5 ]

Ethyl 3-bromo-4,5-dichlorobenzoate

Similarity: 0.88

Esters

Chemical Structure| 933585-58-1

[ 933585-58-1 ]

Methyl 3-bromo-5-chlorobenzoate

Similarity: 0.92

Chemical Structure| 117738-81-5

[ 117738-81-5 ]

Methyl 4-bromo-3,5-dichlorobenzoate

Similarity: 0.91

Chemical Structure| 107947-17-1

[ 107947-17-1 ]

Methyl 3-bromo-4-chlorobenzoate

Similarity: 0.89

Chemical Structure| 1160574-85-5

[ 1160574-85-5 ]

Ethyl 3-bromo-4,5-dichlorobenzoate

Similarity: 0.88

Chemical Structure| 877149-10-5

[ 877149-10-5 ]

Methyl 4-bromo-2-chloro-6-methylbenzoate

Similarity: 0.87